These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 33892201)

  • 21. Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy.
    Peters WP; Rosner G; Ross M; Vredenburgh J; Meisenberg B; Gilbert C; Kurtzberg J
    Blood; 1993 Apr; 81(7):1709-19. PubMed ID: 7681699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fungal infections in hematopoietic stem cell transplantation in children at a pediatric children's hospital in Argentina.
    Gomez SM; Caniza M; Fynn A; Vescina C; Ruiz CD; Iglesias D; Sosa F; Sung L
    Transpl Infect Dis; 2018 Aug; 20(4):e12913. PubMed ID: 29679436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hematopoietic cell transplantation comorbidity index and risk of developing invasive fungal infections after allografting.
    Busca A; Passera R; Maffini E; Festuccia M; Brunello L; Dellacasa CM; Aydin S; Frairia C; Manetta S; Butera S; Iovino G; Giaccone L; Sorror M; Storb R; De Rosa FG; Bruno B
    Bone Marrow Transplant; 2018 Oct; 53(10):1304-1310. PubMed ID: 29654289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Single-Center, Open-Label Trial of Isavuconazole Prophylaxis against Invasive Fungal Infection in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation.
    Stern A; Su Y; Lee YJ; Seo S; Shaffer B; Tamari R; Gyurkocza B; Barker J; Bogler Y; Giralt S; Perales MA; Papanicolaou GA
    Biol Blood Marrow Transplant; 2020 Jun; 26(6):1195-1202. PubMed ID: 32088367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prevention and treatment of febrile neutropenia].
    Montemurro F; Gallicchio M; Aglietta M
    Tumori; 1997; 83(2 Suppl):S15-9. PubMed ID: 9235724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor (rhu GM-CSF) as Adjuvant Therapy for Invasive Fungal Diseases.
    Chen TK; Batra JS; Michalik DE; Casillas J; Patel R; Ruiz ME; Hara H; Patel B; Kadapakkam M; Ch'Ng J; Small CB; Zagaliotis P; Ragsdale CE; Leal LO; Roilides E; Walsh TJ
    Open Forum Infect Dis; 2022 Nov; 9(11):ofac535. PubMed ID: 36381625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-Lasting Protective Effect of Posaconazole Prophylaxis in Patients with Acute Myeloid Leukemia Receiving Allogeneic Hematopoietic Stem Cell Transplantation.
    Busca A; Candoni A; Audisio E; Passera R; Bruno B; Monaco F; Mordini N; Vacca A; Delia M; Aversa F; Pagano L
    Biol Blood Marrow Transplant; 2016 Dec; 22(12):2214-2219. PubMed ID: 27667012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduction in incidence of invasive fungal infection in patients receiving allogeneic stem cell transplantation using combined diagnostic-driven approach and itraconazole oral solution.
    Tzadok R; Shapira MY; Moses AE; Or R; Block C; Strahilevitz J
    Mycoses; 2015 Dec; 58(12):694-8. PubMed ID: 26429354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Invasive fungal infections associated with prior respiratory viral infections in immunocompromised hosts.
    Ajmal S; Mahmood M; Abu Saleh O; Larson J; Sohail MR
    Infection; 2018 Aug; 46(4):555-558. PubMed ID: 29627936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sargramostim in acute radiation syndrome.
    Lazarus HM; McManus J; Gale RP
    Expert Opin Biol Ther; 2022 Nov; 22(11):1345-1352. PubMed ID: 36325797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcome of non-mold effective anti-fungal prophylaxis in patients at high-risk for invasive fungal infections after allogenic stem cell transplantation.
    Christen D; Sohlbach K; Metzelder SK; Wollmer E; Hoeffkes HG; Naumann R; Burchardt A; Rummel M; Trenker C; Dohse M; Mack E; Klameth A; Mann C; Kostrewa P; Brendel C; Wündisch T; Neubauer A; Wilhelm C; Burchert A
    Leuk Lymphoma; 2019 Aug; 60(8):2056-2061. PubMed ID: 30644334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hematopoietic growth factors in cancer patients with invasive fungal infections.
    Offner F
    Eur J Clin Microbiol Infect Dis; 1997 Jan; 16(1):56-63. PubMed ID: 9063675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant human granulocyte macrophage-colony stimulating factor expressed in yeast (sargramostim): A potential ally to combat serious infections.
    Damiani G; McCormick TS; Leal LO; Ghannoum MA
    Clin Immunol; 2020 Jan; 210():108292. PubMed ID: 31676420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiology of infections following haploidentical peripheral blood hematopoietic cell transplantation.
    Slade M; Goldsmith S; Romee R; DiPersio JF; Dubberke ER; Westervelt P; Uy GL; Lawrence SJ
    Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 28030755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sargramostim (rhu GM-CSF) Improves Survival of Non-Human Primates with Severe Bone Marrow Suppression after Acute, High-Dose, Whole-Body Irradiation.
    Clayton NP; Khan-Malek RC; Dangler CA; Zhang D; Ascah A; Gains M; Gardner B; Mockbee C; Keutzer JM; McManus J; Authier S
    Radiat Res; 2021 Feb; 195(2):191-199. PubMed ID: 33302291
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antifungal agents in hematopoietic stem cell transplantation.
    Parameswaran GI; Segal BH; Almyroudis NG
    Curr Pharm Des; 2008; 14(20):2011-21. PubMed ID: 18691111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A clinical analysis of micafungin treatment of pulmonary invasive fungal infection in pediatric patients with acute leukemia or post hematopoietic stem cells transplantation].
    Huang K; Qiu KY; Deng LL; Fang JP; Li Y; Guo HX; Zhou DH
    Zhonghua Er Ke Za Zhi; 2017 Nov; 55(11):844-847. PubMed ID: 29141316
    [No Abstract]   [Full Text] [Related]  

  • 38. Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI study.
    Cordonnier C; Rovira M; Maertens J; Olavarria E; Faucher C; Bilger K; Pigneux A; Cornely OA; Ullmann AJ; Bofarull RM; de la Cámara R; Weisser M; Liakopoulou E; Abecasis M; Heussel CP; Pineau M; Ljungman P; Einsele H; ;
    Haematologica; 2010 Oct; 95(10):1762-8. PubMed ID: 20634495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of granulocyte-macrophage colony-stimulating factor as adjuvant therapy for fungal infection in patients with cancer.
    Bodey GP; Anaissie E; Gutterman J; Vadhan-Raj S
    Clin Infect Dis; 1993 Oct; 17(4):705-7. PubMed ID: 8268354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial.
    Winston DJ; Maziarz RT; Chandrasekar PH; Lazarus HM; Goldman M; Blumer JL; Leitz GJ; Territo MC
    Ann Intern Med; 2003 May; 138(9):705-13. PubMed ID: 12729424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.